Elypta Has Granted A US Patent For Its Liquid Biopsy Method For Cancer Metabolism Based Therapeutics Market
The advent of advanced therapies and the increasing prevalence of cancer around the globe is facilitating the growth of the global cancer metabolism-based therapeutics market . According to the International Agency for Research on Cancer, cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. Targeting cancer metabolism conditions is projected to serve major growth opportunities for rare drugs to treat multiple types of cancer. Changing lifestyle and growing aging population is also contributing to the risk of developing cancer among the population. Cancer metabolism therapy is based on the idea that tumors have a different metabolic process from normal or healthy cells. While normal cells secrete glycogen and glucose, cancer cells exhibit a lack of glycogen and glucose as well as increased levels of lactic acid. Cancer patients also have a decreased ability to use oxygen as well as an i...